SCHEMBL5457927

SCHEMBL5457927

COC(=O)c1cccc(-c2ccccc2C2CC(=O)c3c(C)nc(N)nc3C2)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 9/20 0.53
HSP90AB1 P08238 7/20 0.53
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TRAP1 Q12931 1/20 0.40
TSHR P16473 3/20 0.39
LMNA P02545 2/20 0.39
ADRA2A P08913 1/20 0.39
ADRA1A P35348 1/20 0.39
DHFR P00374 2/20 0.38
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
PDK2 Q15119 1/20 0.37
AXL P30530 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5465100 0.90 HSP90AA1 (0.55) HSP90AA1HSP90AB1NPC1RAB9ATRAP1
SCHEMBL14582323 0.86 HSP90AA1 (0.55) HSP90AA1HSP90AB1TRAP1TSHRLMNA
SCHEMBL14582311 0.85 HSP90AA1 (0.60) HSP90AA1HSP90AB1RAB9ATRAP1TSHR
SCHEMBL14582312 0.84 HSP90AA1 (0.58) HSP90AA1HSP90AB1TRAP1TSHRHPGD
SCHEMBL1780605 0.84 HSP90AA1 (0.70) HSP90AA1HSP90AB1TRAP1TSHRLMNA
SCHEMBL14582359 0.83 HSP90AA1 (0.53) HSP90AA1HSP90AB1TRAP1HPGD
SCHEMBL5466848 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1TRAP1TSHRHPGD
SCHEMBL14582445 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1TRAP1TSHRHPGD
SCHEMBL14582357 0.82 HSP90AA1 (0.55) HSP90AA1HSP90AB1TRAP1
SCHEMBL5463158 0.81 HSP90AA1 (0.53) HSP90AA1HSP90AB1NPC1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed
US-20070027150-A1 2-Amino-quinazolin-5-ones NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027150-A1 2-Amino-quinazolin-5-ones TK1, TK2, SLC1A5 HSP90AA1 3373/4885HSP90AB1 3036/4885NPC1 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.